| scholarly article | Q13442814 |
| P2093 | author name string | Sarah A Hale | |
| Karen M Lounsbury | |||
| Cheung Wong | |||
| P2860 | cites work | Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1 | Q24316075 |
| IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis | Q24320080 | ||
| A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 | ||
| Targeting HIF-1 for cancer therapy | Q27860504 | ||
| HIF-1: mediator of physiological and pathophysiological responses to hypoxia | Q28140835 | ||
| Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions | Q28251400 | ||
| The erythropoietin receptor and its expression in tumor cells and other tissues | Q28297838 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Membrane depolarization mediates phosphorylation and nuclear translocation of CREB in vascular smooth muscle cells. | Q31849063 | ||
| Microenvironment-induced cancer metastasis | Q33950033 | ||
| HIF-1: using two hands to flip the angiogenic switch | Q34146364 | ||
| Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications | Q35903053 | ||
| Regulation of proliferation-survival decisions during tumor cell hypoxia | Q39583941 | ||
| c-Jun and hypoxia-inducible factor 1 functionally cooperate in hypoxia-induced gene transcription. | Q39676079 | ||
| Erythropoietin has an anti-myeloma effect - a hypothesis based on a clinical observation supported by animal studies | Q40531699 | ||
| Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. | Q40583161 | ||
| Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway. | Q40804665 | ||
| Nitric oxide and reactive oxygen species exert opposing effects on the stability of hypoxia-inducible factor-1alpha (HIF-1alpha) in explants of human pial arteries | Q44680984 | ||
| Prostate specific antigen expression is down-regulated by selenium through disruption of androgen receptor signaling | Q44732828 | ||
| Autocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cells | Q47928070 | ||
| Erythropoietin regulates tumour growth of human malignancies | Q48280802 | ||
| Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. | Q53483744 | ||
| Incipient angiogenesis | Q73365440 | ||
| Regulation of the hypoxia-inducible transcription factor 1alpha by the ubiquitin-proteasome pathway | Q74485172 | ||
| Effects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: A possible oxygen effect | Q77753473 | ||
| VEGF and HIF-1alpha expression are increased in advanced stages of epithelial ovarian cancer | Q79366831 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| erythropoietin | Q218706 | ||
| P304 | page(s) | 14-19 | |
| P577 | publication date | 2005-10-13 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Erythropoietin disrupts hypoxia-inducible factor signaling in ovarian cancer cells | |
| P478 | volume | 100 |
| Q36563542 | Antiangiogenic therapy for cancer: an update |
| Q34068226 | Association Between Pharmaceutical Support and Basic Science Research on Erythropoiesis-Stimulating Agents |
| Q35768736 | Carbamylated erythropoietin ameliorates the metabolic stress induced in vivo by severe chronic hypoxia |
| Q34596211 | Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities. |
| Q46362748 | Intravitreal recombinant human erythropoietin: a safety study in rabbits |
| Q37106306 | Safety of intravitreally administered recombinant erythropoietin (an AOS thesis) |
Search more.